Skip to main content
. 2023 Mar 28;14:1733. doi: 10.1038/s41467-023-37254-w

Fig. 1. Structure of PLpro from SARS-CoV-2.

Fig. 1

a Overall structure (PDB entry 7JIR14) colored by domain and selected features labeled. b Interactions between PLpro and the noncovalent inhibitor GRL0617. Selected residues and substrate binding subsites are labeled.